Related Experiment Videos
Bone marrow transplantation in sickle cell anaemia
1Department of Paediatric Haematology, Cliniques Universitaires Saint-Luc, Catholic University of Louvain, Brussels, Belgium.
Blood Reviews
|March 1, 1993
Summary
Sickle cell anaemia, a genetic blood disorder, can be effectively treated with bone marrow transplantation. This therapy has shown significant success in making patients asymptomatic, offering a potential cure for the debilitating condition.
Area of Science:
- Hematology
- Genetics
- Pediatric Medicine
Background:
- Sickle cell anaemia is an inherited disorder caused by a beta globin gene mutation.
- It leads to red blood cell rigidity, vaso-occlusive episodes, and multi-organ damage.
- Progressive splenic dysfunction heightens infection risk in affected individuals.
Purpose of the Study:
- To evaluate the efficacy of allogeneic bone marrow transplantation for sickle cell anaemia.
- To assess the long-term outcomes and complications of this therapeutic approach.
Main Methods:
- Allogeneic bone marrow transplantation was performed on 21 sickle cell anaemia patients.
- Patients were monitored for symptom resolution and haemoglobin electrophoresis patterns.
Main Results:
- Twenty out of 21 patients achieved an asymptomatic status post-transplantation.
- The majority of successful recipients exhibited donor-like haemoglobin electrophoresis patterns.
- One patient experienced fatal complications related to the bone marrow transplantation procedure.
Conclusions:
- Allogeneic bone marrow transplantation is a highly effective treatment for sickle cell anaemia.
- This procedure offers a potential cure, significantly improving patient outcomes.
- Further research into managing transplantation-related complications is warranted.